2008 San Antonio Breast Cancer Symposium

CCO's independent coverage of the 2008 San Antonio Breast Cancer Symposium includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, Expert Recaps, and audio and video Expert Highlights that focus on key issues highlighted at the conference.

Early Breast Cancer
Harold J. Burstein, MD, PhD; Peter Ravdin, MD, PhD; Hope S. Rugo, MD

Metastatic Breast Cancer
Clifford A. Hudis, MD; Kathy D. Miller, MD; Joyce O’Shaughnessy, MD

Prediction and Prognosis
Matthew Ellis, MD, PhD; William J. Gradishar, MD, FACP; Edith A. Perez, MD

American Society of Hematology 2008 Annual Meeting

CCO's independent coverage of the 2008 American Society of Hematology meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, Expert Recaps, and audio and video Expert Highlights that focus on key issues highlighted at the conference.

Acute Leukemias/Myelodysplastic Syndromes
Hagop M. Kantarjian, MD; Alan F. List, MD; Martin S. Tallman, MD

Chronic Lymphocytic Leukemia/Chronic Myeloid Leukemia
Brian Druker, MD; Kanti Rai, MD; William G. Wierda, MD, PhD
 
Lymphomas
Steven Bernstein, MD; Owen A. O'Connor, MD, PhD; Julie M. Vose, MD
 
Multiple Myeloma/Plasma Cell Disorders
William I. Bensinger, MD; Sagar Lonial, MD; Paul G. Richardson, MD

Bone Health and Skeletal Complications in Cancer: Insights Into Pathogenesis, Advances in Management

This new Treatment Update helps clinicians apply current thinking regarding maintaining and optimizing bone health in cancer patients through 4 CME-certified educational modules.

Now Available!

Breast Cancer and Bone Health: New and Emerging Treatment Options

Robert E. Coleman, MD, FRCP, reviews the current understanding of bone loss associated with breast cancer and its treatment and recent clinical trial data on emerging therapies to prevent bone destruction in breast cancer patients.

Optimizing Bone Health in Patients With Prostate Cancer

Matthew R. Smith, MD, PhD, examines advances in managing risk of treatment-related and disease-related bone loss in patients with prostate cancer and in preventing fractures and other skeletal-related events.

Bone Complications in Multiple Myeloma

G. David Roodman, MD, PhD, reviews the evolving understanding of the pathogenesis of bone destruction in multiple myeloma, current treatments to prevent skeletal complications, and emerging potential therapies.

Beyond Breast and Prostate Cancer: Bone Health in Other Solid Tumors

Allan Lipton, MD, discusses current strategies to treat and prevent bone metastases in cancer patients.

Current Research Directions in Glioblastoma Multiforme: Evolutions in Targeted Therapy

CME-Certified Modules:

Current Treatment Options and the Need for Novel Therapeutics in Glioblastomas Patrick Y. Wen, MD, reviews current and emerging therapeutic strategies for newly diagnosed and recurrent glioblastoma multiforme.

Promising Investigational Directions: An Overview of Targeted Therapy in GBM Henry S. Friedman, MD, discusses promising investigational targeted therapies for glioblastoma multiforme.

Coming Soon!

How Do Recent Data Impact Practical Management of Patients With GBM? Henry S. Friedman, MD, James J. Vredenburgh, MD, and Patrick Y. Wen, MD, discuss treating patients with gliomas in light of recent data regarding investigational targeted therapies.

Cases in Point: Risk Factors, Surveillance Strategies, and Treatment Options for Hepatocellular Carcinoma 

Now Available!

Downloadable Slideset:

Cases in Point: Risk Factors, Surveillance Strategies, and Treatment Options for Hepatocellular Carcinoma Review monitoring and surveillance recommendations for HCC and emerging strategies for treatment and management, then download slides for use in your own self-study or presentations.

Improving Survival in Colorectal Cancer Through Optimal Management of Liver Metastases

These Interactive Case Challenges allow you to consider the appropriate treatment decisions for colorectal cancer patients with liver metastases. Compare your answers with those of other participants and receive expert feedback from the faculty members.

CME-Certified Modules:

CME-Certified Interactive Case Challenges:

2008 Annual Meeting of the European Society for Medical Oncology*

CCO’s expert faculty members review the most important and clinically relevant presentations from the 2008 ESMO meeting in the areas of gastrointestinal cancers, genitourinary cancers, and breast cancer.

CME-Certified Conference Reports:

CCO Slideset:

CCO Independent Conference Coverage of the 2008 European Society of Medical Oncology Congress Download slides presenting newly reported data in breast, gastrointestinal, renal, and other cancers

Managing Ovarian Cancer Recurrence: Coupling Novel Therapeutics With Optimal Treatment Decisions

This new Treatment Update delivers an overview of current thinking regarding management of recurrent ovarian cancer through 3 CME-certified educational modules and a downloadable slideset.

• Current Standards in Recurrent Ovarian Cancer
• Clinical Potential of Novel Cytotoxic and Biologic Agents in Ovarian Cancer
• Current Issues and Controversies in the Treatment of Recurrent Ovarian Cancer

Advances in Lymphoproliferative Disease: From Molecular Pathogenesis to Multitargeted Treatment

Through 5 text-based modules, 5 downloadable slidesets, and a debate discussion, CCO's expert faculty members explore current and novel agents used to treat leukemias, lymphomas, and other lymphoproliferative diseases.

• Pathogenesis and Progression of Lymphoproliferative Disease: Evolving Concepts
• Cytotoxic Chemotherapy in a Time of Change
• Monoclonal Antibodies in Lymphoproliferative Disorders: From Rationale to Results
• Mechanism Based Therapies for the Treatment of Lymphoid Leukemias
• Advances in Targeted Therapies for the Treatment of Non-Hodgkin’s Lymphomas
• Debate Session–Strategic Approaches to Therapy: Advances and Challenges

Translating Science Into Clinical Practice: Recent Lessons in EGFR Inhibition, Multitargeted TKIs, and the Tumor Microenvironment

Through 4 CME-certified educational modules and accompanying downloadable slidesets, CCO's expert faculty members explore the use of targeted approaches in the treatment of cancer.

• Targeting Multiple Pathways in the Treatment of Cancer
• EGFR-Targeted Antibodies: Clinical Applications, Treatment Challenges, and Ongoing Scientific Research
• Multitargeted Tyrosine Kinase Inhibitors: Clinical Advances, Synergistic Approaches, and Future Development
• Targeting the Tumor Microenvironment: Ongoing Research, Clinical Updates, and Promising Applications
  

Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology 2008 International Symposium

Matti S. Aapro, MD, and Eduardo Bruera, MD, discuss some of the most important presentations from the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology 2008 International Symposium.

CME-Certified Conference Report:

2008 International Symposium on Supportive Care in Cancer: Conference Report Matti S. Aapro, MD, and Eduardo Bruera, MD, discuss studies presented at the 2008 Supportive Care meeting.

• Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change
  Expert faculty discuss an overview of the etiology and epidemiology of anemia, the role of iron therapy in treating cancer-related anemia, and future directions for ESA therapy in these patients as determined by guidelines recommending their use and recent data from clinical trials and meta-analyses. A case-based presentation also is included to explore the appropriate use of ESAs in oncology patients.
  
  
• Novel Approaches in Frontline Multiple Myeloma Therapy: Understanding the Options and Implications for Transplantation
  Through a CME-certified educational module and 3 Interactive Case Challenges, CCO's expert faculty members explore recent thinking regarding frontline therapy of multiple myeloma.
  
  
• Attacking the Signal at the Switch: Unraveling the Mysteries of mTOR Inhibition in Multiple Tumor Types
  Through 5 CME-certified educational modules, CCO's expert faculty members explore the rationale for mTOR inhibition as an approach to cancer therapy, review the latest trial results in renal cell carcinoma and other solid tumors and hematologic cancers, and discuss how mTOR inhibitors may be integrated into current treatment regimens.
  
  
• Optimizing Treatment Choices in Ovarian Cancer
  Through 3 CME-certified Virtual Presentations, CCO's expert faculty members discuss current clinical management strategies for recurrent/refractory ovarian cancer, including risk factors, screening, surgery, and current and novel agents. Associated downloadable slidesets are available for use in your own presentations.
  
  
• Master Class in Management of Liver Metastases From Colorectal Cancer
  Steven R. Alberts, MD, reviews recent data on current and novel therapeutic approaches for managing liver metastases in patients with colorectal cancer and examines how this knowledge is applied in practice in 3 patient cases.
  
  
• Clinical Issues and Future Directions in Hematologic Malignancies
  Through 6 CME-certified Virtual Presentations, CCO’s expert faculty discuss new data presented at the 2007 Hematology meeting regarding multiple myeloma, non-Hodgkin’s lymphoma, acute leukemias, myelodysplastic syndrome, chronic myeloid leukemia, and chronic lymphocytic leukemia. The accompanying downloadable slidesets can be used for further study or in your own presentations.
  
  
• Treatment Challenges in Myelodysplastic Syndromes
  Through a CME-certified educational module and Interactive Case Challenges, CCO's expert faculty members review the latest data on the treatment of myelodysplastic syndromes and explore realistic clinical situations.
  
  
• Practical Answers to Key Clinical Challenges: Optimizing Patient Outcomes in Breast Cancer
  Based on the results of a readership survey of educational need, Kathy S. Albain, MD; Kathy D. Miller, MD; Hope S. Rugo, MD; and Linda T. Vahdat, MD, discuss breast cancer cases and optimal treatment regimens for patients in the adjuvant, neoadjuvant, and metastatic settings.
  
  
• Melanoma Treatment Update
  Through 4 CME-certified educational modules, CCO’s expert faculty members review the latest data on the treatment of melanoma.
  
  
• Advances in Metastatic Colorectal Cancer: Molecular Pathways, Biomarkers, and Clinical Results
  This series of CME-certified Expert Recaps and accompanying downloadable slidesets provides a comprehensive update on the use of targeted treatments and biomarkers to optimize patient outcomes in metastatic colorectal cancer. Developed with Clinical Care Options' expert faculty members, these slidesets are available for use as a self-study resource or in your own presentations.
  
  
• 6th International Symposium on Translational Research in Oncology
  Through 8 CME-certified slidesets, CCO's expert faculty members, including Program Directors Dennis J. Slamon, MD, PhD, and John Crown, MD, MPH, review the latest data based on translational research in oncology that were presented at the International Translational Research in Oncology meeting held in Dublin, Ireland, in October 2007.
  

• 2008 San Antonio Breast Cancer Symposium*
  
  
• 2008 American Society of Hematology Annual Meeting*
  
  
• 2008 Oncology Nursing Society Annual Congress*
  
  
• 2008 American Society of Clinical Oncology Annual Meeting *
  
  
• 2008 Genitourinary Cancers Symposium*
  
  
• 2008 Gastrointestinal Cancers Symposium*
  
  
  
  

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Liver Metastases in CRC

• Management of Initially Unresectable Liver Metastases in a 65-Year-Old Woman With Colorectal Cancer
• A 52-Year-Old Man With Colon Cancer and Resectable Metachronous Liver Metastases
• A 63-Year-Old Woman With Colorectal Cancer and Metachronous Liver and Lung Metastasis
  
  

Multiple Myeloma

• Clinical Management of a 59-Year-Old Male Patient With Multiple Myeloma and Renal Dysfunction
• Management of a Transplantation-Eligible 58-Year-Old Male With Newly Diagnosed Multiple Myeloma
• Treatment of Newly Diagnosed Multiple Myeloma in a 78-Year-Old Female

MDS Treatment

• Treatment of a 52-Year-Old Man With High-Risk Myelodysplastic Syndrome
• Management of a 69-Year-Old Patient With Deletion 5q Myelodysplastic Syndrome
• Clinical Management of a 69-Year-Old Man With Intermediate-1-Risk Myelodysplastic Syndrome
  

Topics

• Breast Cancer
• Gastrointestinal Cancer
• General Hematology
• Genitourinary Cancer
• Gynecologic Cancer
• Head and Neck Cancer
• Hematologic Malignancies
• Lung Cancer

Resources

• Advanced Search
• Case Challenges
• Live Events
• Slide Download Library
• Free Bookstore

FEATURED VIDEO SEGMENT

Expert Highlight: Acute Leukemias and Myelodysplastic Syndromes
 

Hagop Kantarjian, MD, provides an update of presentations on acute myeloid leukemia, myelodysplastic syndromes, and myelofibrosis. Click here.

Adding Cetuximab to Capecitabine, Oxaliplatin, and Bevacizumab Shortens PFS in Advanced Colorectal Cancer

In patients with advanced colorectal cancer and KRAS mutation, adding cetuximab to capecitabine, oxaliplatin, and bevacizumab is associated with a significant shortening of PFS

Click here for related Capsule Summaries.

Click here for the more slides.

Click here to visit the bookstore.

Click here for more cases.